Skip to Main Content

Christopher M. Borges, et al. Preclinical Development of EDIT-201, a Multigene Edited Healthy Donor NK Cell with Enhanced Anti-Tumor Function and Superior Serial Killing Activity in an Immunosuppressive Environment. Presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology (ASH), December 5-8, 2020.